全文获取类型
收费全文 | 36796篇 |
免费 | 3836篇 |
国内免费 | 1249篇 |
专业分类
耳鼻咽喉 | 75篇 |
儿科学 | 1313篇 |
妇产科学 | 200篇 |
基础医学 | 3158篇 |
口腔科学 | 155篇 |
临床医学 | 3340篇 |
内科学 | 4888篇 |
皮肤病学 | 271篇 |
神经病学 | 535篇 |
特种医学 | 864篇 |
外国民族医学 | 1篇 |
外科学 | 14343篇 |
综合类 | 5300篇 |
现状与发展 | 2篇 |
一般理论 | 1篇 |
预防医学 | 1139篇 |
眼科学 | 201篇 |
药学 | 2564篇 |
19篇 | |
中国医学 | 2789篇 |
肿瘤学 | 723篇 |
出版年
2024年 | 136篇 |
2023年 | 855篇 |
2022年 | 1375篇 |
2021年 | 2317篇 |
2020年 | 1676篇 |
2019年 | 1891篇 |
2018年 | 1739篇 |
2017年 | 1650篇 |
2016年 | 1663篇 |
2015年 | 1719篇 |
2014年 | 2518篇 |
2013年 | 2607篇 |
2012年 | 1867篇 |
2011年 | 2172篇 |
2010年 | 1872篇 |
2009年 | 1655篇 |
2008年 | 1679篇 |
2007年 | 1598篇 |
2006年 | 1501篇 |
2005年 | 1326篇 |
2004年 | 1130篇 |
2003年 | 989篇 |
2002年 | 824篇 |
2001年 | 768篇 |
2000年 | 556篇 |
1999年 | 469篇 |
1998年 | 372篇 |
1997年 | 306篇 |
1996年 | 310篇 |
1995年 | 297篇 |
1994年 | 260篇 |
1993年 | 193篇 |
1992年 | 200篇 |
1991年 | 185篇 |
1990年 | 131篇 |
1989年 | 144篇 |
1988年 | 116篇 |
1987年 | 105篇 |
1986年 | 83篇 |
1985年 | 90篇 |
1984年 | 83篇 |
1983年 | 51篇 |
1982年 | 58篇 |
1981年 | 59篇 |
1980年 | 49篇 |
1979年 | 53篇 |
1978年 | 40篇 |
1977年 | 38篇 |
1976年 | 29篇 |
1975年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
181.
骨髓基质干细胞和神经生长因子悬液移植对脊髓损伤修复的影响 总被引:8,自引:0,他引:8
目的研究骨髓基质干细胞(BMSCs)移植联用神经生长因子(NGF)对脊髓损伤修复的治疗作用。方法用改良Allen法制成SD大鼠脊髓损伤动物模型(共32只),1周后分别将DMEM、BMSCs、NGF和BMSCs NGF移植入脊髓损伤部位即制成四组(每组8只),移植1、2个月后分别采用神经核蛋白(NeuN)抗体、胶质纤维酸性蛋白(GFAP)抗体和神经丝蛋白(NF)抗体进行免疫荧光染色观察移植的BMSCs的存活及分化情况、损伤部位神经纤维的再生情况。HE染色观察脊髓损伤处空洞面积的改变情况。同时采用BBB运动评分观察大鼠运动功能恢复情况。结果移植1、2个月后,部分移植细胞呈NeuN和GFAP阳性,同时实验组可见明显的神经纤维再生。脊髓损伤处的空洞面积明显减小,差异有显著性意义(P<0.05),BBB评分结果比对照组均有明显增高,差异有显著性意义(P<0.05)。在BMSCs NGF组上述改变更加显著。结论BMSCs可在脊髓损伤处分化为神经元和神经胶质细胞,BMSCs和NGF能够减小脊髓损伤处的空洞面积,促进受损轴突的再生和运动功能的恢复,两者联合应用在脊髓损伤修复治疗中具有协同作用。 相似文献
182.
Kidney Disease After Heart and Lung Transplantation 总被引:2,自引:0,他引:2
Kidney disease is a commonly recognized complication of heart and lung transplantation and is associated with increased morbidity and mortality. While the spectrum of kidney disease in this population is wide-ranging, studies indicate that between 3% and 10% of these patients will ultimately develop end-stage renal disease (ESRD). This review examines the risk factors for both acute and chronic kidney injury, with a particular emphasis on the role of calcineurin inhibitor-mediated nephrotoxicity in both these settings. Against the background of current National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines, we have further considered and recommended appropriate strategies for long-term management of kidney disease-related manifestations in heart and lung transplant recipients. Specific aspects addressed include retarding progressive renal injury and minimizing nephrotoxicity, as well as treatment of hypertension, hyperlipidemia and anemia. Finally, for patients in this population with advanced kidney disease, renal replacement therapy options are discussed. Based on the impact of chronic kidney disease on outcomes in both heart and lung recipients, we advocate early referral to a nephrologist for patients displaying evidence of significant renal dysfunction. 相似文献
183.
K. L. Womer H.-U. Meier-Kriesche P. R. Patton K. Dibadj C. M. Bucci D. Foley S. Fujita B. P. Croker R. J. Howard T. R. Srinivas B. Kaplan 《American journal of transplantation》2006,6(1):209-213
BK virus nephropathy (BKVN) is now recognized as a major cause of renal allograft loss. Recent reports suggest that retransplantation in patients with graft loss due to BKVN is safe after return to dialysis. Since early transplantation is associated with improved outcomes, it would be advantageous if this procedure could be performed prior to ultimate graft loss. However, little data are available regarding the safety of this approach during active viremia. In this report, we describe successful preemptive retransplantation with simultaneous allograft nephrectomy in two patients with active BKVN and viremia at the time of surgery. With 21- and 12-month follow-up, respectively, both patients have stable allograft function and no evidence for active viral replication. We conclude that preemptive retransplantation can be considered in patients with failing allografts due to BKVN. 相似文献
184.
185.
Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study 总被引:3,自引:1,他引:2
Patients on cyclosporin A (CsA) often develop hyperuricaemiaand gout. In transplant patients the use of uricosuric drugsfor treating hyperuricaemia may be preferable to allopurinolbecause of the known interaction of the latter with azathioprine.We therefore prospectively studied the uricosuric efficacy of100 mg benzbromarone (Bbr;Desuric®) daily in 25 CsA-treatedrenal transplant patients with stable graft function and hyperuricaemia(>359 µmol/l for females, >491 µmol/l formales). Benzbromarone decreased plasma uric acid from 579±18µmol/l to 313±24 µmol/l (mean±SEM;P<0.001) and thereby normalized plasma uric acid in 21 of25 patients. The remaining four patients had creatininc clearancesbetween 21 and 25 ml/min, the lowest of the entire study group.Mean fractional clearance of uric acid increased from 5.4±0.4%to 17.2±1.0% (P<0.001). The relative decrease of plasmauric acid closely correlated with baseline creatinine clearance(r=0.67; P<0.001). CsA trough values were not influenced.None of the patients experienced any significant side-effects.As an unexpected find-ing, urinary uric acid excretion increasedfrom 2082 ± 175 µmol7sol;24 h to 3233 ±232µmol/24 h after 4 weeks' treatment with benzbromarone. In conclusion, benzbromarone normalized plasma uric acid inall CsA-treated renal transplant recipients with a creatinineclearance >25 ml/min. Due to its excellent efficacy and lackof significant side-effects, benzbromarone appears to be preferableto allopurinol in CsA-treated renal transplant recipients witha creati nine clearance over 25 ml/min. 相似文献
186.
Paula Jablonski Kirsty Baxter Brian O. Howden Anita C. Thomas Vernon C. Marshall Alicia Stein-Oakley Napier M. Thomson 《ANZ journal of surgery》1995,65(2):114-119
A reproducible animal model is essential for the study of the pathogenesis of chronic rejection. This study investigates: (i) the optimal pre-transplant blood transfusion conditions to induce tolerance in a strongly rejecting rat kidney allograft model (Dark Agouti to Albino-Surgery) and avoiding post-transplant immunosuppression; (ii) the functional and histological changes that occur in long-term surviving kidneys and their similarity to chronic rejection; and (iii) the maintenance of tolerance. Prolonged survival occurred after administration of at least two donor blood transfusions with concomitant cyclosporin A (5 mg/kg per day). The time-span between transfusions appeared to be critical: 4 days was more effective than 2 or 7 days. Ineffective treatment led to death within the first 2 weeks post-transplant with histological evidence of acute graft rejection. Seventy-five per cent of long-term survivors experienced impaired renal function in the first week which improved spontaneously and remained stable in 93% of the surviving animals after 100 days and in 668 after 200 days. The morphology of long-term allografts was extremely variable from minor to extensive tubular atrophy, interstitial fibrosis, glomerular hypertrophy, focal and segmental glomerulosclerosis and vascular changes. Glomerular hypertrophy occurred in uninephrectomized controls and probably denoted a response to uninephrectomy. Glomerulosclerosis increased with time and was absent in controls. Although chronic damage was evident, the rats remained tolerant to fresh donor skin. Replacement of the original kidney allograft with a fresh donor kidney resulted in 70% survival. These second grafts showed less severe renal dysfunction and morphological damage than the original allografts in the long-term follow up. 相似文献
187.
F. J. B. Sampaio 《Urological research》1992,20(4):271-274
Summary The growth of fetal kidney volume was studied in 290 specimens taken from 145 fresh human fetuses (85 males and 60 females) with gestational age ranging from 13 to 36 weeks postconception (WPC). Normative equations and curves of the growth of renal volume were obtained for male and female fetuses and for the whole sample in the second trimester (13–24 WPC) and in the third trimester (25–36 WPC) of gestation. There was no difference between the growth in volume of the right and left kidneys. Fetal kidney volume increases with a more intense rhythm in the early fetal period (13–24 WPC). During the second trimester, there was no difference between the values for renal volume of male and female fetuses. In the third trimester, male fetuses had renal volumes significantly greater than the female fetuses. The normative parameters of renal volume could have practical applications in detection and monitoring of renal anomalies in fetal and perinatal urology.Supported by grants 302, 369/86.4/BM-FV from the National Conucil of Scientific and Technological Development (CNPq, Brazil) and Grant E.29/170.787/89 from the Rio de Janeiro Foundation for Research Support (FAPERJ). 相似文献
188.
24条本地健康杂种犬随机分成3组:①切脾组;②对照组;③自体脾组织移植组。实验表明犬自体脾块大网膜内移植存活良好,并恢复部分脾功能。切脾后犬周围血嗜中性粒细胞的细菌吞噬率和杀菌功能均低于正常犬,而行脾组织移植后能使之接近正常水平。但移植脾的脾小体中T淋巴细胞数和红髓中单核吞噬细胞数均少于正常脾组织。 相似文献
189.
W L de Kort M A Verschoor A A Wibowo J J van Hemmen 《American journal of industrial medicine》1987,11(2):145-156
A group of workers, occupationally exposed to lead and cadmium compounds (n = 53), was compared to a group of workers not exposed to these metals (n = 52). The average values of systolic, diastolic, and mean blood pressure were found to be higher in the exposed group (p less than 0.05). In contrast with the correlation between CdU and blood pressure, the correlation between PbB and systolic and mean blood pressure remained statistically significant after controlling for age and pulse rate (r = 0.22, p less than 0.05). The prevalence of potential hypertension (defined as systolic blood pressure greater than or equal to 160 mm Hg and/or diastolic blood pressure greater than or equal to 95 mm Hg and/or under treatment for hypertension) was higher in the exposed group, but the observed relative risk was not statistically significant: relative risk = 1.91 (95% confidence limits, 0.90-4.05). Furthermore, a significant correlation between PbB and Hgb (r = -0.28, p = 0.004) was observed. Differences in kidney function, as assessed in this study, were not detected. 相似文献
190.
Levin Adeera; Djurdjev Ognjenka; Duncan John; Rosenbaum Debbie; Werb Ron 《Nephrology, dialysis, transplantation》2006,21(2):370-377
Haemoglobin (Hgb) levels are known to be associated with numerousadverse outcomes in both chronic kidney disease (CKD) and non-CKDpatients. This analysis evaluates the association of baseline haemoglobinlevels on survival in CKD patients, who are followed by nephrologists,irrespective of glomerular filtration rate (GFR), prior to initiationof renal replacement therapy (RRT) and erythropoietin hormonereplacement therapy. Analysis of data from the provincial database (PROMIS, PatientRegistration and Outcome Management Information System) in BritishColumbia, Canada, was undertaken. Records used for the analysisincluded all CKD patients at first registration: GFR <60ml/min/1.73 m2, not yet on dialysis, starting from May 1998to October 2002, and who had complete data (defined as age andgender, diabetic status, eGFR and Hgb levels). The primary objective of this study was to determine the associationof Hgb and survival controlling for eGFR at first registrationvalue, age, gender and diabetic status. Multivariate Cox proportionalhazards analysis with time to death as outcome variable wasperformed. The cohort included 3028 patients: the mean age was 65 years,28% were diabetic, and the mean eGFR in the cohort was 21 ml/min/1.73m2. The cohort is representative of the BC CKD and dialysispopulation regarding ethnicity: 64% Caucasian, 32% Asian. Medianfollow-up was 27 months, 1 year survival was 0.92, 2 year survivalwas 0.85. Hgb at initial registration is a statistically independentpredictor of survival (RR = 0.875 for every 10 g/l, 95% CI:0.8350.917, P = 0.0001), after adjusting for age, gender,diabetic status and baseline eGFR. Further analysis, controllingfor RRT, demonstrated a similar association between Hgb andsurvival (RR = 0.853 for every 10 g/l, 95% CI: 0.7990.910,P = 0.0001), after adjusting for above variables. Substantialvariation in Hgb values exists at all GFR levels. These findings underscore the importance of evaluating Hgb atall GFR levels, and the need to study the impact of modificationof Hgb at different GFR levels on survival. 相似文献